Oil and gas production management company Core Laboratories NV (CLB) on Wednesday reported a 29 percent increase in profit for the second quarter on higher revenues and operating margins.
Adjusted earnings beat analysts' estimates by a penny, while revenues missed their expectations. Looking ahead to the third quarter, the company forecast results mostly below analysts estimates.
According to the Netherlands-based Core Laboratories, the strong second-quarter results reflected its continued focus on worldwide crude-oil related and large LNG projects, especially those involved with the development of deepwater fields offshore West and East Africa, the eastern Mediterranean, Brazil, and the Gulf of Mexico.
Segment-wise, revenues from reservoir description operations, which focus on deepwater international and Gulf of Mexico crude-oil projects, grew 6 percent from last year to $126.46 million.
Production enhancement operations revenues, with more exposure to North American markets, recorded a 12 percent increase in revenues to $99.55 million. Revenues from the reservoir management operations increased 15 percent to $21.00 million from the prior-year quarter.
Core Laboratories' net income for the second quarter was $52.92 million or $1.11 per share, up from $40.45 million or $0.83 per share in the prior-year quarter.
Excluding items, net income rose to $55.35 million or $1.16 per share from $43.87 million or $0.90 per share in the same period last year. On average, eight analysts polled by Thomson Reuters expected the company to report earnings of $1.15 per share. Analysts' estimates typically exclude special items.
Revenue for the quarter grew 9 percent to $247.01 million from $225.79 million in the year-ago quarter, but missed analysts' consensus revenue estimate of $251.43 million.
Core Laboratories noted that North American rig counts were down slightly from year-end 2011, while international rig counts were up only 4 percent over year-ago totals.
Operating margin for the quarter was 31 percent, an all-time quarterly high for Core Laboratories.
Looking ahead to the third quarter, Core Laboratories forecasts earnings in a range of $1.17 per share to $1.25 per share and revenues of about $250 million to $260 million. Analysts expect the company to earn $1.24 per share for the quarter on revenues of $263.72 million.
For fiscal 2012, Core expects to generate about $200 million in free cash flow, while increasing capital expenditures to an estimated $33 million.
CLB closed Wednesday's trading at $116.45, up $1.92 or 1.68 percent on a volume of 548,550 shares. In after-hours, the stock declined $0.22 or 0.19 percent to $116.23.
For comments and feedback contact: editorial@rttnews.com
Business News
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.